Cell Therapy News Volume 22.28 | Aug 9 2021

    0
    54







    2021-08-09 | CTN 2.28


    Cell Therapy News by STEMCELL Technologies
    Vol. 2.28 – 9 August, 2021
    TOP STORY

    Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

    In this single-center, Phase I trial, scientists administered anti-CD7 chimeric antigen receptor (CAR) T cells, manufactured from either previous stem-cell transplantation donors or new donors, to patients with relapsed or refractory T-cell acute lymphoblastic leukemia, in single infusions at doses of 5 × 105 or 1 × 106 cells per kilogram of body weight.
    [Journal of Clinical Oncology]

    Abstract
    Attend the Cell and Gene Therapy virtual conference!
    PUBLICATIONSRanked by the impact factor of the journal

    Prevention of Vascular-Allograft Rejection by Protecting the Endothelial Glycocalyx with Immunosuppressive Polymers

    Researchers showed that protecting the endothelial glycocalyx in vascular allografts via the enzymatic ligation of immunosuppressive glycopolymers under cold-storage conditions attenuated the acute and chronic rejection of the grafts after transplantation in the absence of systemic immunosuppression.
    [Nature Biomedical Engineering]

    Abstract

    A Broad and Systematic Approach to Identify B-Cell Malignancy Targeting TCRs for Multi-Antigen Based T Cell Therapy

    Scientists isolated a broad range of promising TCRs targeting multiple antigens for treatment of B-cell malignancies. 28 target genes for B-cell malignancies were selected based on gene expression profiles.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Decrease Post-Transplant Relapse Using Donor-Derived Expanded NK-Cells

    In this Phase I/II clinical trial, the authors investigated the safety and efficacy of high doses of mb-IL21 ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid malignancies receiving haploidentical stem-cell transplantation.
    [Leukemia]

    Full Article

    Transplantation of Human Autologous Synovial Mesenchymal Stem Cells with Trisomy 7 into the Knee Joint and 5 Years of Follow-Up

    Investigators determined the ratio of patients whose synovial MSCs were transplanted clinically, to intensively investigate MSCs with trisomy 7 from a safety perspective, and to follow up the patients for five years after transplantation.
    [Stem Cells Translational Medicine]

    Full Article

    Exosomes Derived from Human Umbilical Cord Blood Mesenchymal Stem Cells Stimulate Regenerative Wound Healing via Transforming Growth Factor-β Receptor Inhibition

    To determine the function of umbilical cord blood (UCB)-MSCs, the authors examined and compared the therapeutic effects of UCB-MSCs and UCB-MSC-derived exosomes on skin healing in rats.
    [Stem Cell Research & Therapy]

    Full Article

    Comparison of the Biological and Functional Characteristics of Mesenchymal Stem Cells from Intrahepatic and Identical Bone Marrow

    Scientists compared the biological and functional characteristics of naïve MLpvNG2 cells with identical bone marrow-derived MSCs using in vitro and in vivo procedures.
    [Stem Cell Research]

    Full Article

    Mesenchymal Stem Cells from Different Sources Show Distinct Therapeutic Effects in Hyperoxia-Induced Bronchopulmonary Dysplasia in Rats

    Researchers evaluated intratracheal MSCs as an approach to treat an hyperoxia-induced bronchopulmonary dysplasia animal model and compared the therapeutic effects between amniotic fluid-, umbilical cord- and bone marrow-MSCs.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    Transplantable Human Motor Networks as a Neuron-Directed Strategy for Spinal Cord Injury

    The authors formed encapsulated, transplantable neuronal networks of regionally matched cervical spinal motor neurons, interneurons, and oligodendrocyte progenitor cells derived through trunk-biased neuromesodermal progenitors.
    [iScience]

    AbstractGraphical Abstract

    Impact of Endoscopic Submucosal Dissection and Epithelial Cell Sheet Engraftment on Systemic Cytokine Dynamics in Patients with Oesophageal Cancer

    Researchers investigated the comprehensive cytokine dynamics following endoscopic submucosal dissection in patients with oesophageal cancer.
    [Scientific Reports]

    Full Article
    The Immunology Podcast is here. Find it wherever you get your podcasts.
    REVIEWS

    From Bench to Bedside: Single-Cell Analysis for Cancer Immunotherapy

    The authors review current approaches to sample processing and computational analysis regarding their application to translational cancer immunotherapy research.
    [Cancer Cell]

    Abstract

    Epigenetic Strategies to Boost CAR T Cell Therapy

    Investigators outlined how epigenetic modifications in CAR T cells can overcome barriers limiting CAR T cell effectiveness, particularly in immunosuppressive tumor microenvironments.
    [Molecular Therapy]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Trial to Use Stem Cells in Baby Hearts

    The University of Michigan Health C.S. Mott Children’s Hospital is among the first study sites to begin applying stem cell therapy to babies with single ventricle heart disease.
    [Michigan Medicine]

    Press Release

    Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer

    Kite, a Gilead Company and Appia Bio, Inc. announced a collaboration and license agreement to research and develop hematopoietic stem cells-derived cell therapies directed toward hematological malignancies.
    [Kite, a Gilead Company]

    Press Release

    FEATURED EVENT

    EMBO: Molecular Mechanisms of Aging and Regeneration: From Hydra to Humans

    September 6 – 10, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – CAR T-Cell Studies

    Baylor College of Medicine – Houston, Texas, United States

    Research Scientist – Cancer Immunotherapy Drug Discovery

    Incyte – Wilmington, Delaware, United States

    Researcher – Lymphoid Malignancies and Cellular Therapies

    University of California, San Francisco – San Francisco, California, United States

    Postdoctoral Scholar – Immunology, Cancer Immunotherapy, and Protein Engineering

    University of California Irvine – Irvine, California, United States

    Postdoctoral Positions – Stem Cell-Based Therapy

    UCLA Jules Stein Eye Institute – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter